## Abstract Six transplanted rat tumours (three mammary carcinomas and three fibrosarcomas), all of spontaneous origin and of limited immunogenicity, have been examined for susceptibility to immunotherapy with BCG (Glaxo). Growth of limited numbers of cells from five tumours was suppressed when cel
Bcg therapy of pleural and peritoneal growth of transplanted rat tumours
✍ Scribed by M. V. Pimm; R. W. Baldwin
- Book ID
- 102868275
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- French
- Weight
- 652 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Growth of intrapleurally injected cells of immunogenic methylcholanthrene‐induced rat sarcomas was suppressed by intrapleural injection of viable or 1 × 10^6^ R radiationsterilized BCG vaccine. As little as 10 μg moist weight of organisms was effective, and treatment could be given several days before or after tumour challenge. Pleural effusion growth of a moderately immunogenic ascitic hepatoma was also controlled by intrapleurally administered BCG. In contrast, BCG injected intravenously, subcutaneously or intraperitoneally was without influence on pleural tumour growths. Similarly, intraperitoneal growth of these tumours was suppressed only by intraperitoneal injection of BCG. With two other transplanted tumours, a chemically induced mammary carcinoma and a spontaneous sarcoma, both of which lack significant immunogenicity, BCG treatment of pleural and peritoneal growths was less successful and more variable. Nevertheless, these studies indicate the potential of this type of treatment of thoracic and peritoneal tumour deposits for possible clinical application in the treatment of malignant mesothelioma.
📜 SIMILAR VOLUMES
## Abstract Growth of syngeneic transplants of methylcholanthrene‐induced sarcomas and an aminoazo‐dye‐induced hepatoma in rats was suppressed when tumour cells were injected in admixture with BCG vaccine containing living organisms, or vaccine sterilized by exposure to 1 to 3 × 10^6^ R γ‐irradiati
## Abstract __C. parvum__ (Wellcome CN 6134) has been tested for tumour suppression against a range of syngeneically transplanted rat tumours, both carcinogen‐induced and of spontaneous origin. Subcutaneous growth was not prevented by distant subcutaneous or intravenous injection of the preparation